Welcome to Dwaey, specifically on Fexofenadine Hydrochloride + Pseudoephedrine Hydrochloride page.
This medicine contains important and useful components, as it consists of
Fexofenadine Hydrochloride + Pseudoephedrine Hydrochloride is available in the market in concentration.
Fexofenadine Hydrochloride + Pseudoephedrine Hydrochloride
The combination of fexofenadine hydrochloride and pseudoephedrine hydrochloride is commonly used to treat symptoms of allergic rhinitis, such as nasal congestion, sneezing, and runny nose. While generally safe, several precautions should be observed when using this combination. Patients with a history of cardiovascular conditions, such as hypertension, heart disease, or arrhythmias, should use this combination with caution. Pseudoephedrine is a decongestant that works by constricting blood vessels in the nasal passages, and in some individuals, it can cause increased blood pressure, rapid heart rate, or irregular heartbeat. This medication should also be used with caution in individuals with hyperthyroidism, diabetes, or glaucoma, as pseudoephedrine can exacerbate these conditions. Fexofenadine is generally non-sedating, but when combined with pseudoephedrine, some people may experience increased stimulation, leading to insomnia or nervousness. Pregnant women should use this combination only if the benefits outweigh the potential risks, particularly because pseudoephedrine may affect blood flow to the fetus. The drug should be avoided in breastfeeding mothers unless recommended by a healthcare provider, as both components can pass into breast milk in small amounts. Patients with severe renal impairment should use this medication with caution and under close supervision, as both drugs are excreted by the kidneys.
The combination of fexofenadine hydrochloride and pseudoephedrine hydrochloride is indicated for the treatment of symptoms associated with allergic rhinitis, including nasal congestion, sneezing, itching, and watery eyes. Fexofenadine is an antihistamine that helps relieve allergy symptoms by blocking the action of histamine, a chemical involved in allergic reactions. Pseudoephedrine is a decongestant that works by constricting blood vessels in the nasal passages to reduce swelling and congestion. This combination is effective in treating seasonal and perennial allergic rhinitis, especially in patients who experience both nasal congestion and other allergy symptoms. It is also used to treat symptoms of the common cold, although it is not intended to treat the underlying viral infection. This combination is often preferred in patients who need relief from both histamine-induced symptoms (e.g., sneezing, itchy eyes) and nasal congestion. Off-label uses may include the treatment of sinusitis or relief from nasal congestion associated with upper respiratory infections. However, it should not be used in individuals with a history of chronic rhinitis or sinusitis without proper consultation with a healthcare provider.
Fexofenadine hydrochloride and pseudoephedrine hydrochloride are contraindicated in individuals with known hypersensitivity or allergic reactions to any of the components. This combination is also contraindicated in patients with severe hypertension, coronary artery disease, or other significant cardiovascular conditions. Pseudoephedrine can increase blood pressure and heart rate, which may exacerbate these conditions. The medication should be avoided in individuals with narrow-angle glaucoma, urinary retention, or hyperthyroidism, as pseudoephedrine may worsen these conditions. This combination is also contraindicated in patients with a history of seizures, as pseudoephedrine can lower the seizure threshold. Fexofenadine and pseudoephedrine should not be taken with monoamine oxidase inhibitors (MAOIs), as serious drug interactions may occur, potentially leading to hypertensive crises or other adverse effects. Additionally, this combination is contraindicated in children under 12 years of age, as its safety and efficacy have not been established in younger pediatric populations. In patients with severe renal or hepatic impairment, the use of this combination should be carefully considered and monitored by a healthcare provider.
The combination of fexofenadine hydrochloride and pseudoephedrine hydrochloride can cause side effects, some of which may be related to either or both components. The most common side effects include dry mouth, headache, dizziness, and mild gastrointestinal symptoms such as nausea or indigestion. Pseudoephedrine may cause nervousness, insomnia, or restlessness due to its stimulating effects, especially when taken in high doses. Some patients may also experience increased blood pressure or heart rate, which can be problematic for individuals with pre-existing cardiovascular conditions. Less commonly, fexofenadine can cause drowsiness, though this is less likely compared to first-generation antihistamines. Rarely, more severe allergic reactions such as skin rash, swelling, or difficulty breathing may occur, which would require immediate medical attention. Prolonged use of pseudoephedrine can lead to rebound nasal congestion, where symptoms may worsen once the drug is stopped. In some cases, both fexofenadine and pseudoephedrine may cause dizziness or drowsiness, making it difficult to perform tasks that require full alertness, such as driving or operating machinery. If any severe side effects, such as chest pain, irregular heartbeat, or difficulty breathing, occur, medical attention should be sought immediately.
3
Fexofenadine hydrochloride is an antihistamine that works by blocking the H1 histamine receptors, preventing histamine from binding to these receptors and triggering allergic symptoms such as itching, sneezing, and watery eyes. Fexofenadine does not cross the blood-brain barrier as easily as first-generation antihistamines, making it less likely to cause sedation or central nervous system (CNS) depression. Pseudoephedrine hydrochloride is a sympathomimetic drug that works as a decongestant by stimulating alpha-adrenergic receptors in the smooth muscles of blood vessels in the nasal passages. This causes vasoconstriction (narrowing of blood vessels), which reduces swelling and congestion in the nasal passages, making it easier to breathe through the nose. Together, the combination of fexofenadine and pseudoephedrine targets both the histamine-mediated symptoms of allergies (such as sneezing and itching) and the nasal congestion that often accompanies them. Fexofenadine’s selective action on peripheral H1 receptors allows it to provide relief from allergy symptoms without significant sedative effects, while pseudoephedrine's vasoconstrictive effects alleviate nasal blockage.
Fexofenadine hydrochloride and pseudoephedrine hydrochloride can interact with several drugs and substances, which may alter their effectiveness or increase the risk of side effects. Pseudoephedrine can interact with other sympathomimetic drugs, such as certain decongestants, beta-agonists, and amphetamines, potentially causing excessive stimulation, increased blood pressure, or heart rate. Caution should be exercised when combining this medication with other antihypertensive medications, as pseudoephedrine may counteract their effects. Fexofenadine’s absorption can be affected by fruit juices like grapefruit, orange, and apple juice, which can reduce its bioavailability, so it is advised to avoid consuming these juices when taking this medication. Fexofenadine can also interact with antacids containing aluminum or magnesium, which can decrease the absorption of fexofenadine. To avoid this interaction, antacids should be taken at least 2 hours before or after taking fexofenadine. The combination of fexofenadine and pseudoephedrine may also interact with other CNS stimulants, such as caffeine, leading to increased nervousness, anxiety, or insomnia. It is advised to avoid combining these medications without consulting a healthcare provider.
For adults, the typical dose of fexofenadine hydrochloride and pseudoephedrine hydrochloride is one tablet of the combined 180 mg fexofenadine/240 mg pseudoephedrine formulation once daily. This dose is usually sufficient to relieve symptoms of seasonal allergic rhinitis or chronic rhinitis and nasal congestion. If additional relief is needed, some patients may take one tablet twice daily, but this should only be done under the direction of a healthcare provider. The dose should not exceed two tablets per day, as higher doses may increase the risk of side effects, particularly related to pseudoephedrine. The medication should be taken with water, and patients should avoid taking it with fruit juices, as these can reduce the absorption of fexofenadine. If the patient has kidney or liver impairment, dose adjustments may be necessary. Prolonged use of this combination should be avoided unless directed by a healthcare provider, as long-term decongestant use may lead to rebound congestion.
The use of fexofenadine hydrochloride and pseudoephedrine hydrochloride in children is not recommended for those under 12 years of age due to safety concerns and lack of established dosing guidelines in younger populations. For children aged 12 years and older, the typical dose is the same as for adults: one tablet of the combined 180 mg fexofenadine/240 mg pseudoephedrine formulation once daily. If additional symptom relief is required, the dose may be increased to one tablet twice daily under the supervision of a healthcare provider. Children should be closely monitored for any side effects, particularly nervousness, restlessness, or an increase in blood pressure. As with adults, the combination should not be taken with fruit juices, as this can interfere with the absorption of fexofenadine.
For patients with renal impairment, the dose of fexofenadine hydrochloride and pseudoephedrine hydrochloride should be adjusted carefully. Fexofenadine is primarily excreted through the kidneys, so in patients with moderate to severe renal impairment (creatinine clearance below 80 mL/min), the dose of fexofenadine may need to be reduced to 60 mg once daily. Pseudoephedrine is also excreted via the kidneys, and in patients with renal impairment, its elimination may be slower, potentially leading to an increased risk of side effects such as increased heart rate or blood pressure. For patients with severe renal impairment, this combination may not be recommended, and an alternative treatment should be considered. Close monitoring of kidney function and the patient's response to the medication is necessary in these cases.
Not available in a medicine form yet